Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss

This publication has 41 references indexed in Scilit:

• Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer
  British Journal of Cancer, 2012
• Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
  JNCI: Journal of the National Cancer Institute, 2011
• Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
  British Journal of Cancer, 2011
• Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
  Annals of Oncology, 2011
• Aromatase, aromatase inhibitors, and breast cancer
  The Journal of Steroid Biochemistry and Molecular Biology, 2011
• Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
  JNCI: Journal of the National Cancer Institute, 2009
• Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications
  Journal of Clinical Pathology, 2008
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
  New England Journal of Medicine, 2004
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001
• Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis
  Science, 1975